PLEXI-T Trademark
Trademark Overview
On Monday, August 19, 2024, a trademark application was filed for PLEXI-T with the United States Patent and Trademark Office. The USPTO has given the PLEXI-T trademark a serial number of 98705565. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 6, 2025. This trademark is owned by TScan Therapeutics, Inc.. The PLEXI-T trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer
Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer
General Information
Serial Number | 98705565 |
Word Mark | PLEXI-T |
Filing Date | Monday, August 19, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, May 6, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 6, 2025 |
Trademark Statements
Goods and Services | Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer |
Pseudo Mark | PLEXI T |
Goods and Services | Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, August 19, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, August 19, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | TScan Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Waltham, MA 02451 |
Party Name | TScan Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Waltham, MA 02451 |
Trademark Events
Event Date | Event Description |
Monday, August 19, 2024 | NEW APPLICATION ENTERED |
Saturday, March 8, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Sunday, March 9, 2025 | ASSIGNED TO EXAMINER |
Tuesday, April 1, 2025 | NON-FINAL ACTION WRITTEN |
Tuesday, April 1, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, April 1, 2025 | NON-FINAL ACTION E-MAILED |
Thursday, April 3, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, April 3, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, April 3, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, April 4, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 30, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 6, 2025 | PUBLISHED FOR OPPOSITION |
Tuesday, May 6, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |